不妊治療サービスの日本市場の評価：不妊原因別、処置別、サービス別、プロバイダー別、地域別、機会、予測（2018年度～2032年度）

日本の不妊治療サービスの市場規模は、2024年度の30億5,000万米ドルから2032年度に50億4,000万米ドルに達すると予測され、2025年度～2032年度の予測期間にCAGRで6.50%の成長が見込まれます。市場の成長は、不妊症患者の増加、人口増加を後押しする政府の施策の増加、急速な技術の進歩、不妊治療技術の社会的受容の高まりによって後押しされています。

日本の急速な人口減少により、不妊治療サービスの需要は大幅に増加しています。Carnegie Endowment for International Peaceの推計によると、2050年までに日本の各都道府県は人口の約42%を失います。秋田県の人口は2020年に96万人でしたが、2050年までに56万人に減少すると推定されています。人口減少により日本が直面するさまざまな課題に対処するため、少子化対策サービスへの依存度が著しく高まっています。こうした課題には、労働人口の減少、経済の縮小、医療部門への依存の増大などが含まれます。

一方、不妊症患者の増加や不妊治療サービスの社会的受容の高まりも、日本の不妊治療サービス市場の拡大を後押ししています。歴史的に、日本では不妊は汚名とされてきました。しかし、教育キャンペーンや認知度の向上により、不妊治療に対する社会的認識が変化し、日本における不妊治療の普及が進んでいます。代理出産や体外受精（IVF）を含む代替的な家族づくりの選択肢への文化的シフトが、日本における不妊治療サービス市場の拡大と成長をさらに後押ししています。さらに、生殖技術の進歩が不妊治療サービスの有効性と効果を高め、その採用をさらに後押ししています。

当レポートでは、日本の不妊治療サービス市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 日本の不妊治療サービス市場の見通し（2018年度～2032年度）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • 不妊原因別
  • 処置別
  • サービス別
  • プロバイダー別
  • 地域別
  • 市場シェア分析（上位5社とその他、金額）（2024年度）
• 市場マップ分析（2024年度）
  • 不妊原因別
  • 処置別
  • サービス別
  • プロバイダー別
  • 地域別

第5章 需給分析

第6章 ポーターのファイブフォース分析

第7章 PESTLE分析

第8章 価格分析

第9章 市場力学

• 市場促進要因
• 市場の課題

第10章 市場の動向と発展

第11章 規制枠組みとイノベーション

第12章 ケーススタディ

第13章 競合情勢

• マーケットリーダー上位5社の競合マトリクス
• 上位5社のSWOT分析
• 主要企業上位10社の情勢
  • Fertility Clinic Tokyo
  • Fertility World
  • St. Mother Hospital
  • Oak Clinic Inc.
  • Natural ART Clinic Nihombashi
  • IUHW Hospital IVF Center
  • Sanno Hospital
  • Kamijo Women's Clinic
  • Jichi Medical University Hospital
  • Kusuhara Women's Clinic

第14章 戦略的提言

第15章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Fertility Services Market, By Value, In USD Billion, FY2018-FY2032F
• Figure 2. Japan Fertility Services Market Share (%), By Cause of Infertility, FY2018-FY2032F
• Figure 3. Japan Fertility Services Market Share (%), By Procedure, FY2018-FY2032F
• Figure 4. Japan Fertility Services Market Share (%), By Service, FY2018-FY2032F
• Figure 5. Japan Fertility Services Market Share (%), By Provider, FY2018-FY2032F
• Figure 6. Japan Fertility Services Market Share (%), By Region, FY2018-FY2032F
• Figure 7. By Cause of Infertility Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 8. By Procedure Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 9. By Service Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 10. By Provider Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 11. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2024

Japan fertility services market is projected to witness a CAGR of 6.50% during the forecast period FY2025-FY2032, growing from USD 3.05 billion in FY2024 to USD 5.04 billion in FY2032. The market's growth is propelled by the rising cases of infertility, increasing government measures to boost population growth, rapid technological advancements, and rising social acceptance of fertility technologies.

Due to the rapid population decline in Japan, the demand for fertility services is significantly increasing. According to the estimates of the Carnegie Endowment for International Peace, by 2050 various Japanese prefectures would lose about 42% of their population. The population of the Akita Prefecture was 960,000 in 2020 and is estimated to fall to 560,000 by 2050. In order to combat the various challenges faced by the country due to the declining population growth, the reliance on fertility services is significantly increasing. These challenges include a reduced working population, a shrinking economy, and increasing dependency on the healthcare sector.

Meanwhile, the growing cases of infertility and increasing social acceptance of fertility services are also augmenting the expansion of the Japan fertility services market. Historically, infertility was stigmatized in Japan. However, rising educational campaigns and increasing awareness have transformed the public perception of such treatments and increased their adoption in Japan. The cultural shift towards alternative family building options including surrogacy and in-vitro fertilization (IVF) is further propelling the expansion and growth of the fertility services market in Japan. Moreover, advancements in reproductive technologies enhance the efficacy and effectiveness of fertility services, further encouraging their adoption.

Supportive Government Initiatives Boost Market Expansion

In order to improve the country's fertility rate, the government is taking various measures and introducing new policies and incentives, supporting the expansion of the Japan fertility services market. For instance, in 2022, six new surgical codes (K-codes) were introduced by the country's national health service for infertility treatments. The additional fertilization procedures included testicular sperm extraction, IVF, embryo culture, transfer and freezing, and intracytoplasmic sperm injection (ICSI). Moreover, the government discussion regarding public health insurance covering normal births, i.e., births without complications are being slated for 2026. Such efforts can be attributed to the country's low fertility rate and the significant demographic challenges faced by Japan, such as reduced workforce and expansion of the aging population. Government initiatives and support aim to alleviate the financial burdens associated with fertility services, thus promoting increased birth rates.

Rapid Expansion of the Aging Population Bolsters Market's Demand

The rapid expansion of the country's aging population is one of the major factors propelling the requirement for fertility services in Japan. Due to the significant growth of the population over the age of sixty-five, the country is facing various demographic challenges that include increased healthcare costs and a shrinking workforce. In order to mitigate such challenges, the Japanese government is focusing on developing policies and introducing initiatives that support family planning, providing lucrative growth opportunities for the market. This increased focus on fertility support includes the provision of funding for different assisted reproductive technologies (ART), including IVF, whose requirement is becoming more prevalent in the country as the population delays marriage and childbirth to focus on professional growth and development. Therefore, the reliance on fertility services is significantly increasing in Japan.

Rising Requirement for Fertility Preservation Services Boost Market Expansion

The increasing reliance on fertility preservation services can be attributed to the growing cases of infertility, delayed pregnancies due to the increasing participation of women in the workforce, and rising awareness and acceptance of such treatments. Thus, the government is also focusing on introducing various programs and schemes to support the population in their fertility preservation efforts. As of January 2024, more than 7,000 women have registered for information sessions for Tokyo's fertility subsidy program, which offers up to USD 2,023 (300,000 yen) for egg freezing and was launched in 2022. Egg freezing is one of the most preferred services opted by women for extending their fertility, the cost of which usually runs from USD 1,974 to USD 3,949, with some running up to USD 6,582. Preserving younger eggs is preferred by a large number of working women to increase their chances of conception, thus augmenting the requirement for fertility preservation services and providing lucrative growth opportunities for the market.

Fertility Clinics Account for Significant Market Share

The growth of fertility clinics can be attributed to the presence of skilled professionals and advanced technologies across these facilities. Moreover, the growing adoption of smart devices and novel technologies and services across these facilities also supports the segment's growth. Additionally, fertility clinics offer personalized treatment plans and services that cater to the individual requirements of the patient population, enhancing the effectiveness of the treatments. The increasing acceptance and awareness about fertility services along with the rising cases of both male and female infertility in Japan are also contributing to the growth and expansion of fertility clinics in the country.

Future Market Scenario (FY2025 - FY2032F)

According to the Japan fertility services market analysis, the market is expected to observe significant growth over the forecast period due to increasing government efforts to bolster population growth, increasing incidences of infertility, technological advancements in fertility technologies, and rising awareness about the various treatment options available.

The rising income levels are also supporting the market's growth in the country. As per the estimates of the Statistics Bureau of Japan, the average monthly income per household for 2024 was USD 7771.29 (1,179,259 yen), up by 2.9% in real terms and 7.2% in nominal terms from the previous year.

Increasing efforts of the Japanese government to incentivize childbirth are also expected to bolster the market's expansion. The government is considering covering all expenses for childbirth under the public medical insurance system in the coming years to combat the declining birthrates.

Key Players Landscape and Outlook

Many startups are stepping up to address the soaring demand for fertility services in Japan. Startups such as ARCH, Inc. focus on enhancing clinical efficiency and addressing the various challenges faced by the patient population undergoing fertility treatments. Additionally, various policies and technologies are being introduced to address the fertility crisis faced by the country that are also supporting the expansion of such startups. Government initiatives, along with increasing societal acceptance of fertility treatments, are allowing the growth of fertility startups in Japan.

Additionally, Japanese pharmaceutical giants are investing in advanced treatments and technologies in order to improve treatment outcomes and provide lucrative growth opportunities for the market. For instance, in August 2024, Rohto Pharmaceutical Co., Ltd. joined BAIBYS Fertility Ltd.'s Series A funding round. The system developed by the latter examines sperm samples and selects the specimen that is most ideal as per the criteria of the WHO. The automated approach adopted by the company ensures the affordability and accessibility of advanced fertility treatments and addresses the inefficiencies of traditional methods.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Fertility Services Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Cause of Infertility
    • 4.2.1.1. Male Infertility
    • 4.2.1.2. Female Infertility
  • 4.2.2. By Procedure
    • 4.2.2.1. In-vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
    • 4.2.2.2. Intrauterine Insemination (IUI)
    • 4.2.2.3. In-vitro Fertilization without Intracytoplasmic Sperm Injection (IVF without ICSI)
    • 4.2.2.4. Surrogacy
    • 4.2.2.5. Others
  • 4.2.3. By Service
    • 4.2.3.1. Fresh non-donor
    • 4.2.3.2. Frozen non-donor
    • 4.2.3.3. Egg and Embryo Banking
    • 4.2.3.4. Fresh Donor
    • 4.2.3.5. Frozen Donor
  • 4.2.4. By Provider
    • 4.2.4.1. Fertility Clinics
    • 4.2.4.2. Hospitals
    • 4.2.4.3. Others
  • 4.2.5. By Region
    • 4.2.5.1. North [Hokkaido and Tohoku]
    • 4.2.5.2. Central [Kanto and Chubu]
    • 4.2.5.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
  • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Cause of Infertility
  • 4.3.2. By Procedure
  • 4.3.3. By Service
  • 4.3.4. By Provider
  • 4.3.5. By Region

5. Demand Supply Analysis

6. Porter's Five Forces Analysis

7. PESTLE Analysis

8. Pricing Analysis

9. Market Dynamics

• 9.1. Market Drivers
• 9.2. Market Challenges

10. Market Trends and Developments

11. Regulatory Framework and Innovation

12. Case Studies

13. Competitive Landscape

• 13.1. Competition Matrix of Top 5 Market Leaders
• 13.2. SWOT Analysis for Top 5 Players
• 13.3. Key Players Landscape for Top 10 Market Players
  • 13.3.1. Fertility Clinic Tokyo
    • 13.3.1.1. Company Details
    • 13.3.1.2. Key Management Personnel
    • 13.3.1.3. Products and Services
    • 13.3.1.4. Financials (As Reported)
    • 13.3.1.5. Key Market Focus and Geographical Presence
    • 13.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 13.3.2. Fertility World
  • 13.3.3. St. Mother Hospital
  • 13.3.4. Oak Clinic Inc.
  • 13.3.5. Natural ART Clinic Nihombashi
  • 13.3.6. IUHW Hospital IVF Center
  • 13.3.7. Sanno Hospital
  • 13.3.8. Kamijo Women's Clinic
  • 13.3.9. Jichi Medical University Hospital
  • 13.3.10. Kusuhara Women's Clinic

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us and Disclaimer